» Authors » Rosanna Mallamaci

Rosanna Mallamaci

Explore the profile of Rosanna Mallamaci including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 237
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mallamaci R, Castellani S, Limosani F, Medaglia P, Fracchiolla G, Cardone R, et al.
Int J Pharm . 2025 Feb; 673:125399. PMID: 39999902
The aim of the present work was to evaluate the performance of slightly viscous dispersions (SVDs) of the mucoadhesive oxidized alginate (Alg OX) with or without hydroxypropylmethyl cellulose (HPMC) as...
2.
Mallamaci R, Barbarossa A, Carrieri A, Meleleo D, Carocci A
Int J Mol Sci . 2024 Aug; 25(15). PMID: 39125623
Cadmium (Cd) toxicity poses a significant threat to cellular health, leading to oxidative stress and cell damage. Antioxidant agents, particularly those of natural origin, have been studied as a potential...
3.
Castellani S, Mallamaci R, De Giglio E, Caponio A, Guerra L, Fracchiolla G, et al.
Int J Pharm . 2024 May; 659:124255. PMID: 38782151
With the aim to find an alternative vehicle to the most used thermosensitive hydrogels for efficient nanotechnology-based nose-to-brain delivery approach for Parkinson's disease (PD) treatment, in this work we evaluated...
4.
Carvalho T, Audero M, Greco M, Ardone M, Maggi T, Mallamaci R, et al.
Cells . 2024 May; 13(9. PMID: 38727266
Background: Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with high mortality due to early metastatic dissemination and high chemoresistance. All these factors are favored by its extracellular matrix (ECM)-rich...
5.
Mallamaci R, Musaro D, Greco M, Caponio A, Castellani S, Munir A, et al.
Molecules . 2024 Apr; 29(8). PMID: 38675592
Parkinson's disease (PD) is a prevalent neurodegenerative disorder, primarily associated with dopaminergic neuron depletion in the Substantia Nigra. Current treatment focuses on compensating for dopamine (DA) deficiency, but the blood-brain...
6.
Mallamaci R, Conforti F, Statti G, Avato P, Barbarossa A, Meleleo D
Life (Basel) . 2024 Apr; 14(4). PMID: 38672765
The present study aims to highlight the cell protective effect of Tropea red onion (TRO) hydroalcoholic extract and some of its components against "non-essential" heavy metals. For this purpose, the...
7.
Mallamaci R, Barbarossa A, Carocci A, Meleleo D
Foods . 2024 Feb; 13(3). PMID: 38338554
Ellagic acid (EA), a polyphenolic constituent of plant origin, has been thoroughly investigated for its hypothesised pharmacological properties among which antioxidant and neuroprotective activities are included. The present study was...
8.
Mallamaci R, Storelli M, Barbarossa A, Messina G, Valenzano A, Meleleo D
Int J Mol Sci . 2023 Dec; 24(23). PMID: 38069399
, a filamentous microalga, is used all over the world as a nutraceutical dietary supplement. Recent studies have focused on examining its chelating activity and antioxidant properties, especially as a...
9.
De Giglio E, Bakowsky U, Engelhardt K, Caponio A, La Pietra M, Cometa S, et al.
Molecules . 2023 Dec; 28(23). PMID: 38067437
(1) Background: DA-Gelucire 50/13-based solid lipid nanoparticles (SLNs) administering the neurotransmitter dopamine (DA) and the antioxidant grape-seed-derived proanthocyanidins (grape seed extract, GSE) have been prepared by us in view of...
10.
Meleleo D, Cibelli G, Valenzano A, Mastrodonato M, Mallamaci R
Membranes (Basel) . 2023 Nov; 13(11). PMID: 37999364
The calcium ion (Ca) has been linked to type 2 diabetes mellitus (T2DM), although the role of Ca in this disorder is the subject of intense investigation. Serum Ca dyshomeostasis...